"Designing Growth Strategies is in our DNA"

U.S. Epinephrine for Anaphylaxis Treatment Market Size, Share & Industry Analysis, By Product Type (Autoinjectors, Prefilled Syringes, and Others), By Type (Branded and Generics), By Distribution Channel (Hospitals Pharmacies and Online & Retail Pharmacies), and Country Forecast, 2024-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI110494

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Incidence of Anaphylaxis, 2023
    2. New Product Launches, Key Players
    3. Key Industry Developments Mergers, Acquisitions & Partnerships
    4. Pricing Analysis, Key Products- Key Players, 2023
    5. Technological Advancements
    6. Impact of COVID-19 on the Market
  5. U.S. Epinephrine for Anaphylaxis Treatment Market Analysis, Insights and Forecast, 2019-2032
    1. Market (Revenue, ASP, and Volume) Analysis, Insights and Forecast – By Product Type
      1. Autoinjectors
      2. Prefilled Syringes 
      3. Others
    2. Market (Revenue, ASP, and Volume) Analysis, Insights and Forecast – By Type
      1. Branded
      2. Generics
    3. Market (Revenue, ASP, and Volume) Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Online & Retail Pharmacies
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2023)
    2. Company Profiles
      1. Viatris Inc.
        1. Overview
        2. Financials (based on availability of data)
        3. Recent Developments
        4. Strategies
        5. SWOT, Etc.
      2. Teva Pharmaceutical Industries Ltd.
        1. Overview
        2. Financials (based on availability of data)
        3. Recent Developments
        4. Strategies
        5. SWOT, Etc.
      3. Amneal Pharmaceuticals LLC
        1. Overview
        2. Financials (based on availability of data)
        3. Recent Developments
        4. Strategies
        5. SWOT, Etc.
      4. DMK Pharmaceuticals
        1. Overview
        2. Financials (based on availability of data)
        3. Recent Developments
        4. Strategies
        5. SWOT, Etc.
      5. ALK-Abelló A/S
        1. Overview
        2. Financials (based on availability of data)
        3. Recent Developments
        4. Strategies
        5. SWOT, Etc.
      6. ARS Pharmaceuticals Operations, Inc.
        1. Overview
        2. Financials (based on availability of data)
        3. Recent Developments
        4. Strategies
        5. SWOT, Etc.
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Incidence of Anaphylaxis, 2023
    2. New Product Launches, Key Players
    3. Key Industry Developments Mergers, Acquisitions & Partnerships
    4. Pricing Analysis, Key Products- Key Players, 2023
    5. Technological Advancements
    6. Impact of COVID-19 on the Market
  5. U.S. Epinephrine for Anaphylaxis Treatment Market Analysis, Insights and Forecast, 2019-2032
    1. Market (Revenue, ASP, and Volume) Analysis, Insights and Forecast – By Product Type
      1. Autoinjectors
      2. Prefilled Syringes 
      3. Others
    2. Market (Revenue, ASP, and Volume) Analysis, Insights and Forecast – By Type
      1. Branded
      2. Generics
    3. Market (Revenue, ASP, and Volume) Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Online & Retail Pharmacies
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2023)
    2. Company Profiles
      1. Viatris Inc.
        1. Overview
        2. Financials (based on availability of data)
        3. Recent Developments
        4. Strategies
        5. SWOT, Etc.
      2. Teva Pharmaceutical Industries Ltd.
        1. Overview
        2. Financials (based on availability of data)
        3. Recent Developments
        4. Strategies
        5. SWOT, Etc.
      3. Amneal Pharmaceuticals LLC
        1. Overview
        2. Financials (based on availability of data)
        3. Recent Developments
        4. Strategies
        5. SWOT, Etc.
      4. DMK Pharmaceuticals
        1. Overview
        2. Financials (based on availability of data)
        3. Recent Developments
        4. Strategies
        5. SWOT, Etc.
      5. ALK-Abelló A/S
        1. Overview
        2. Financials (based on availability of data)
        3. Recent Developments
        4. Strategies
        5. SWOT, Etc.
      6. ARS Pharmaceuticals Operations, Inc.
        1. Overview
        2. Financials (based on availability of data)
        3. Recent Developments
        4. Strategies
        5. SWOT, Etc.
Read Less

Figure 1: U.S. Epinephrine for Anaphylaxis Treatment Market Revenue Breakdown (USD billion, %) by Product Type, 2023 & 2032

Figure 2: U.S. Epinephrine for Anaphylaxis Treatment Market Value Share (%), by Product Type, 2023 & 2032

Figure 3: U.S. Epinephrine for Anaphylaxis Treatment Market Value Share (%), by Type, 2023 & 2032

Figure 4: U.S. Epinephrine for Anaphylaxis Treatment Market Value Share (%), by Distribution Channel, 2023 & 2032

Figure 05: U.S. Epinephrine for Anaphylaxis Treatment Market Share (%), 2023

Table 1: U.S. Epinephrine for Anaphylaxis Treatment Market Revenue (USD billion) Forecast, by Product Type, 2019–2030

Table 02: U.S. Epinephrine for Anaphylaxis Treatment Market Average Selling Price (ASP) (USD) Forecast, By Product Type, 2019-2032

Table 03: U.S. Epinephrine for Anaphylaxis Treatment Market Volume (million units) Forecast, By Product Type, 2019-2032

Table 04: U.S. Epinephrine for Anaphylaxis Treatment Market Revenue (USD billion) Forecast, By Type, 2019–2032

Table 05: U.S. Epinephrine for Anaphylaxis Treatment Market Average Selling Price (ASP) (USD) Forecast, By Type, 2019-2032

Table 06: U.S. Epinephrine for Anaphylaxis Treatment Market Volume (million units) Forecast, By Type, 2019-2032

Table 07: U.S. Epinephrine for Anaphylaxis Treatment Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2032

Table 08: U.S. Epinephrine for Anaphylaxis Treatment Market Average Selling Price (ASP) (USD) Forecast, By Distribution Channel, 2019-2032

Table 09: U.S. Epinephrine for Anaphylaxis Treatment Market Volume (million units) Forecast, By Distribution Channel, 2019-2032

U.S. Epinephrine for Anaphylaxis Treatment Market
  • 2019-2032
  • 2023
  • 2019-2022
  • 82
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports